ICCC — ImmuCell Corporation

Stock analysis, AI verdict, fundamentals & technical signals

Rating: HOLD

Price: $10.26 Analyst target: $14.00 Upside: 36.45%

About ImmuCell Corporation

ImmuCell Corporation, an animal health company, develops, manufactures and markets products that improve the health and productivity of dairy and beef cattle in the United States and internationally. The company is headquartered in Portland, Maine.

See the full interactive analysis & chart →

Informational only — not investment advice.